Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Haraoui · SciRah

Researcher profile · Semantic Scholar

B. Haraoui

Share profile

B. Haraoui — researcher profile on SciRah

h-index: 54
Works: 313
Citations: 15K

Most-cited papers

Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis.
A. Rubbert-Roth, J. Enejosa, A. Pangan, B. Haraoui +5 more
2020New England Journal of Medicine226 citations
Semantic Scholar
Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study.
J. Smolen, G. Burmester, B. Combe, J. Curtis +9 more
2016The Lancet173 citations
Semantic Scholar
Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies
K. Papp, B. Haraoui, Deepali Kumar, J. Marshall +10 more
2018Journal of Cutaneous Medicine and Surgery104 citations Open access
Semantic Scholar
Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study
T. Takeuchi, M. Genovese, B. Haraoui, Zhan-Guo Li +9 more
2017Annals of the Rheumatic Diseases76 citations Open access
Semantic Scholar
Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set
V. Bykerk, C. Bingham, E. Choy, D. Lin +16 more
2016RMD Open58 citations Open access
Semantic Scholar
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission
J. Curtis, P. Emery, E. Karis, B. Haraoui +4 more
2020Arthritis & Rheumatology50 citations Open access
Semantic Scholar
Psoriasis and Smoking
V. Richer, C. Roubille, P. Fleming, Tara Starnino +12 more
2016Journal of Cutaneous Medicine and Surgery48 citations
Semantic Scholar
Overweight, Obesity, and the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results From a Multicenter Prospective Cohort Study
E. Schulman, S. Bartlett, O. Schieir, K. Andersen +10 more
2018Arthritis care & research41 citations
Semantic Scholar
A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population.
A. Kivitz, S. Cohen, E. Keystone, R. van Vollenhoven +7 more
2018Seminars in Arthritis & Rheumatism38 citations Open access
Semantic Scholar
Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry
D. Choquette, L. Bessette, E. Alemao, B. Haraoui +3 more
2019Arthritis Research & Therapy37 citations Open access
Semantic Scholar
Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort.
C. Hitchon, G. Boire, B. Haraoui, E. Keystone +5 more
2016Rheumatology34 citations Open access
Semantic Scholar
Methotrexate withdrawal in patients with rheumatoid arthritis who achieve low disease activity with tofacitinib modified-release 11 mg once daily plus methotrexate (ORAL Shift): a randomised, phase 3b/4, non-inferiority trial.
S. Cohen, J. Pope, B. Haraoui, F. Irazoque-Palazuelos +8 more
2019The Lancet Rheumatology33 citations Open access
Semantic Scholar
Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open‐Label, Long‐Term Extension Studies up to 9.5 Years
J. Pope, E. Keystone, S. Jamal, Lisy Wang +5 more
2019ACR Open Rheumatology32 citations Open access
Semantic Scholar
The effect of rheumatoid arthritis–associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis
L. Barra, J. Pope, C. Hitchon, G. Boire +8 more
2017Rheumatology32 citations
Semantic Scholar
Experience with tofacitinib in Canada: patient characteristics and treatment patterns in rheumatoid arthritis over 3 years.
J. Pope, L. Bessette, N. Jones, L. Fallon +5 more
2019Rheumatology27 citations Open access
Semantic Scholar
Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary
K. Papp, B. Haraoui, Deepali Kumar, John K. Marshall +10 more
2019Journal of Rheumatology27 citations Open access
Semantic Scholar
Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registry
P. Rahman, M. Zummer, L. Bessette, P. Baer +10 more
2017BMJ Open24 citations Open access
Semantic Scholar
Early Rheumatoid Arthritis Presentation, Treatment, and Outcomes in Aboriginal Patients in Canada: A Canadian Early Arthritis Cohort Study Analysis
Sujay Nagaraj, C. Barnabe, O. Schieir, J. Pope +8 more
2018Arthritis care & research20 citations
Semantic Scholar
Reduction in Serum Uric Acid May Be Related to Methotrexate Efficacy in Early Rheumatoid Arthritis: Data from the Canadian Early Arthritis Cohort (CATCH)
Jason J. Lee, V. Bykerk, G. Dresser, G. Boire +7 more
2016Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders18 citations Open access
Semantic Scholar
Treatment Strategies in Early Rheumatoid Arthritis Methotrexate Management: Results From a Prospective Cohort
C. Moura, O. Schieir, M. Valois, C. Thorne +24 more
2020Arthritis care & research17 citations
Semantic Scholar
Use of a baseline risk score to identify the risk of serious infectious events in patients with rheumatoid arthritis during certolizumab pegol treatment
J. Curtis, K. Winthrop, C. O’brien, Matladi N. Ndlovu +2 more
2017Arthritis Research & Therapy17 citations Open access
Semantic Scholar
Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b/4 methotrexate withdrawal non-inferiority study (ORAL Shift)
S. Cohen, J. Pope, B. Haraoui, E. Mysler +8 more
2021RMD Open16 citations Open access
Semantic Scholar
High Adherence to System‐Level Performance Measures for Rheumatoid Arthritis in a National Early Arthritis Cohort Over Eight Years
C. Barber, O. Schieir, D. Lacaille, D. Marshall +13 more
2018Arthritis care & research16 citations Open access
Semantic Scholar
A Bridge Too Far? Real‐World Practice Patterns of Early Glucocorticoid Use in the Canadian Early Arthritis Cohort
K. Andersen, O. Schieir, M. Valois, S. Bartlett +23 more
2021ACR Open Rheumatology14 citations Open access
Semantic Scholar
Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
P. Rahman, P. Baer, E. Keystone, D. Choquette +9 more
2020BMC Rheumatology13 citations Open access
Semantic Scholar
Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
B. Kuriya, O. Schieir, D. Lin, J. Xiong +9 more
2017Clinical and Experimental Rheumatology13 citations
Semantic Scholar
Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study
A. Rubbert-Roth, K. Kato, B. Haraoui, M. Rischmueller +4 more
2024Rheumatology and Therapy12 citations Open access
Semantic Scholar
An open-label randomized controlled trial of DMARD withdrawal in RA patients achieving therapeutic response with certolizumab pegol combined with DMARDs.
J. Pope, E. Rampakakis, J. Vaillancourt, L. Bessette +3 more
2019Rheumatology11 citations
Semantic Scholar
Tocilizumab Patterns of Use, Effectiveness, and Safety in Patients with Rheumatoid Arthritis: Final Results from a Set of Multi-National Non-Interventional Studies
B. Haraoui, G. Casado, L. Czirják, Andrew Taylor +4 more
2019Rheumatology and Therapy11 citations Open access
Semantic Scholar
Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study
B. Haraoui, S. Jamal, V. Ahluwalia, D. Fung +2 more
2018Rheumatology and Therapy11 citations Open access
Semantic Scholar
SAT0151 EFFICACY AND SAFETY OF UPADACITINIB VERSUS ABATACEPT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-CHOICE): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL
A. Rubbert-Roth, J. Enejosa, A. Pangan, R. Xavier +6 more
2020Annals of the Rheumatic Diseases10 citations
Semantic Scholar
Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study
B. Haraoui, M. Khraishi, D. Choquette, L. Lisnevskaia +9 more
2022Arthritis care & research9 citations Open access
Semantic Scholar
Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study
L. Bessette, B. Haraoui, A. Chow, I. Fortin +8 more
2019Therapeutic Advances in Musculoskeletal Disease9 citations Open access
Semantic Scholar
Effectiveness of a treat-to-target strategy in patients with moderate to severely active rheumatoid arthritis treated with abatacept
L. Bessette, B. Haraoui, E. Rampakakis, Joanna Dembowy +2 more
2023Arthritis Research & Therapy8 citations Open access
Semantic Scholar
Associations Between Safety of Certolizumab Pegol, Disease Activity, and Patient Characteristics, Including Corticosteroid Use and Body Mass Index
V. Bykerk, A. Blauvelt, J. Curtis, C. Gaujoux-Viala +6 more
2021ACR Open Rheumatology7 citations Open access
Semantic Scholar
Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies—Executive Summary
K. Papp, B. Haraoui, Deepali Kumar, J. Marshall +10 more
2019Journal of the Canadian Association of Gastroenterology7 citations Open access
Semantic Scholar
Dose Escalation and Co-therapy Intensification Between Etanercept, Adalimumab, and Infliximab: The CADURA Study
C. Thorne, G. Boire, A. Chow, K. Garces +4 more
2017Open Rheumatology Journal6 citations Open access
Semantic Scholar
Impact of Methotrexate Discontinuation, Interruption, or Persistence in US Patients with Rheumatoid Arthritis Initiating Tofacitinib + Oral Methotrexate Combination.
S. Cohen, B. Haraoui, J. Curtis, T. Smith +3 more
2022Clinical Therapeutics5 citations Open access
Semantic Scholar
Efficacy of Long-Term Treatment with Once-Daily Baricitinib 2 mg in Patients with Active Rheumatoid Arthritis: Post Hoc Analysis of Two 24-Week, Phase III, Randomized, Controlled Studies and One Long-Term Extension Study
A. Wells, B. Jia, Li Xie, G. Valenzuela +6 more
2021Rheumatology and Therapy5 citations Open access
Semantic Scholar
FRI0127 Outcomes of disease activity in a 5-year large cohort of rheumatoid arthritis patients treated under treat to target recommendations and a multidisciplinary care model – a real-life experience
P. Taylor, R. Alten, B. Haraoui, B. Amess +6 more
20175 citations Open access
Semantic Scholar
Defining and characterizing sustained remission in patients with rheumatoid arthritis
J. Curtis, M. Trivedi, B. Haraoui, P. Emery +4 more
2017Clinical Rheumatology5 citations Open access
Semantic Scholar
FRI0066 The 28-Joint Disease Activity Score (DAS28) Using C-Reactive Protein Yields Lower Thresholds Compared To Conventional DAS28 with Erythrocyte Sedimentation Rate in Early Rheumatoid Arthritis
B. Kuriya, O. Schieir, D. Lin, J. E. Pope +7 more
20165 citations
Semantic Scholar
Tofacitinib Safety and Effectiveness in Canadian Patients with Rheumatoid Arthritis by Cardiovascular Risk Enrichment: Subanalysis of the CANTORAL Study
B. Haraoui, M. Khraishi, D. Choquette, I. Fortin +7 more
2024Rheumatology and Therapy4 citations Open access
Semantic Scholar
Real-World Effectiveness and Safety of SDZ ETN, an Etanercept Biosimilar, in Patients with Rheumatic Diseases: Final Results from Multi-Country COMPACT Study
M. Schmalzing, H. Kellner, Ayman Askari, Javier De Toro Santos +14 more
2023Advances in Therapy4 citations Open access
Semantic Scholar
Post-switch Effectiveness of Etanercept Biosimilar Versus Continued Etanercept in Rheumatoid Arthritis Patients with Stable Disease: A Prospective Multinational Observational Study
J. Pope, S. Hall, C. Bombardier, B. Haraoui +9 more
2022Advances in Therapy4 citations Open access
Semantic Scholar
Predicting Low Disease State and Remission in Early Rheumatoid Arthritis in the First Six Months, Comparing the Simplified Disease Activity Index and European League Against Rheumatism Response Measures: Results From an Early Arthritis Cohort
M. Omair, E. Keystone, V. Bykerk, D. Lin +9 more
2017Arthritis care & research4 citations
Semantic Scholar
THU0174 A Safety Analysis of Tofacitinib 5 mg Twice Daily Administered as Monotherapy or in Combination with Background Conventional Synthetic Dmards in A Phase 3 Rheumatoid Arthritis Population
A. Kivitz, B. Haraoui, J. Kaine, V. Castellano +4 more
20164 citations
Semantic Scholar
Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate
R. Fleischmann, B. Haraoui, M. Buch, D. Gold +4 more
2022Rheumatology and Therapy3 citations Open access
Semantic Scholar
Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis
J. Curtis, B. Stolshek, P. Emery, B. Haraoui +5 more
2022Journal of clinical rheumatology3 citations Open access
Semantic Scholar
“From Where I Stand”: using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ)
S. Bartlett, V. Bykerk, O. Schieir, M. Valois +21 more
2021Quality of Life Research3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Pope×19
Invite
J. Pope — researcher profile on SciRah
E. Keystone×15
Invite
E. Keystone — researcher profile on SciRah
S. Jamal×14
Invite
S. Jamal — researcher profile on SciRah
V. Bykerk×14
Invite
V. Bykerk — researcher profile on SciRah

×14

Invite

G. Boire — researcher profile on SciRah

Invite

C. Hitchon — researcher profile on SciRah

Invite

D. Tin — researcher profile on SciRah

Invite

O. Schieir — researcher profile on SciRah

Invite

J. Curtis — researcher profile on SciRah

Invite

C. Thorne — researcher profile on SciRah

Invite

E. Keystone — researcher profile on SciRah

Invite

D. Lin — researcher profile on SciRah